Broadcom Under the Microscope: Insider Sales, Sector Weakness and a Curious Valuation Gap to Marvell

A puzzling discrepancy has emerged among the two dominant players in custom AI chips: Marvell Technology now commands a significantly higher valuation than Broadcom, despite the latter’s far larger scale and broader product base. The divergence, highlighted in a recent Wall Street analysis, pits Marvell’s premium for faster expected growth against Broadcom’s discount for diversification and market heft. Both companies serve the same hyperscaler clients — Google, Meta, OpenAI, and Apple — yet investors are paying markedly different multiples, a dynamic that has sharpened attention on Broadcom’s current share price.

Broadcom’s stock has drifted lower from its early-June peak, with the shares closing Monday at €336.85 — nearly 22% below the 52-week high of €429.60 reached on June 3. That retreat has been accompanied by a flurry of insider selling that, when tallied since June 25, amounts to an estimated $29.9 million in completed and announced transactions. On July 8 alone, Chief Legal and Corporate Affairs Officer Mark Brazeal sold 25,000 shares at an average price of $379.19, while director Gayla Delly disposed of 1,890 shares at roughly $385.38. Brazeal’s haul from that single sale was approximately $9.48 million, and Delly’s brought in $728,368. The two executives reduced their holdings by 5.69% and 10.2%, respectively, yet still retain positions worth tens of millions of dollars — Brazeal alone continues to hold more than 219,000 shares valued at around $83.4 million. Insider sales of this scale are routinely chalked up to portfolio diversification, but the timing, just as the stock tests critical technical levels, has kept traders on edge.

The broader semiconductor landscape has compounded the pressure. A global rout in chip stocks was triggered in part by SK Hynix, which plunged 15.4% in Seoul after reports of a potential second-quarter profit decline. The Philadelphia Semiconductor Index subsequently dropped nearly 5%. Adding to the unease are rising geopolitical tensions between the US and Iran, which have pushed oil prices higher and revived concerns about supply chains. Analysts have also flagged a potential helium shortage, pointing to blocked shipping routes in the Middle East that could disrupt the supply of the gas essential to high-end chip manufacturing.

Should investors sell immediately? Or is it worth buying Broadcom?

None of this has dampened Broadcom’s fundamental story in artificial intelligence. The company’s AI-related revenue soared 143% year-over-year in the latest quarter to $10.8 billion, and management is holding to its target of $100 billion in cumulative AI revenue by 2027. The custom-chip client list — Google, Meta, OpenAI, and Apple — provides a competitive moat that few rivals can match. A strategic pillar is the recently sealed chip-supply agreement with Apple, valued at $30 billion and running through 2031. The pact focuses on high-performance radio-frequency components and domestic US production, with Broadcom committing $1.5 million in facility investment in Colorado.

Despite the June peak-to-trough decline, the stock remains solidly in positive territory on longer time frames. It is up 42.6% over the past 12 months and has gained 13.6% year-to-date. Even the 30-day view shows a gain of roughly 3.5%, underscoring that the latest pullback follows an extended run rather than a reversal of a full-year trend. On a technical basis, Broadcom is now testing the 50-day moving average of €350.36, trading about 3.9% below that level. A sustained break below the 50-day would shift attention to the 100-day moving average at €324.95, while the 200-day average stands at €312.97, more than 9% above the current price. The 30-day annualized volatility sits above 61%, and the relative strength index is neutral at 51.3, suggesting the stock is consolidating after the sharp swings of late June and early July.

Analysts on Wall Street have not flinched. The consensus rating remains “Strong Buy,” with an average price target implying upside of more than 28% from current levels. The narrative around “AI fatigue” — investor weariness with hype-driven rallies — has surfaced across the sector, but Broadcom’s own numbers show little sign of a slowdown. For now, the stock is caught between a booming AI pipeline and a confluence of headwinds: insider sales, geopolitical fog, and a curious valuation gap to a smaller rival. Which force wins out may depend on whether the shares can reclaim the 50-day line and prove the recent weakness is merely a pause in a longer ascent.

Ad

Broadcom Stock: New Analysis - 14 July

Fresh Broadcom information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Broadcom analysis...

en | US11135F1012 | BROADCOM | boerse | 69762812 |